Literature DB >> 27005556

Small molecules modulating tumor-stromal cell interactions: new candidates for anti-tumor drugs.

Manabu Kawada1.   

Abstract

The tumor microenvironment comprises tumor cells surrounding normal cells and the extracellular matrix. The surrounding normal cells have critical roles in the regulation of growth and metastasis of cancers, including the maintenance of cancer stem cells and the formation of cancer metastatic niches. Recent anti-tumor strategies targeting the tumor microenvironment have included inhibition of angiogenesis and the augmentation of immune reactions. However, in this review, we will focus on stromal cells (fibroblast-like cells), a common constituent of the tumor microenvironment. Since stromal cells regulate the growth of cancer cells positively and negatively through adhesion and secreted factors, anti-tumor strategies should consider modulating tumor-stromal cell interactions through use of small molecules.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27005556     DOI: 10.1038/ja.2016.37

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  13 in total

1.  NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716.

Authors:  Manabu Kawada; Tetsuya Someno; Hiroyuki Inoue; Shun-ichi Ohba; Tohru Masuda; Taira Kato; Daishiro Ikeda
Journal:  J Antibiot (Tokyo)       Date:  2010-04-30       Impact factor: 2.649

2.  Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.

Authors:  Yasuhide Hori; Kenichiro Ishii; Hideki Kanda; Yoichi Iwamoto; Kohei Nishikawa; Norihito Soga; Hideaki Kise; Kiminobu Arima; Yoshiki Sugimura
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

3.  Interactions between cancer stem cells and their niche govern metastatic colonization.

Authors:  Ilaria Malanchi; Albert Santamaria-Martínez; Evelyn Susanto; Hong Peng; Hans-Anton Lehr; Jean-Francois Delaloye; Joerg Huelsken
Journal:  Nature       Date:  2011-12-07       Impact factor: 49.962

4.  Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.

Authors:  Chun-Peng Liao; Helty Adisetiyo; Mengmeng Liang; Pradip Roy-Burman
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

5.  Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.

Authors:  Manabu Kawada; Hiroyuki Inoue; Tohru Masuda; Daishiro Ikeda
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

6.  Synthesis of intervenolin, an antitumor natural quinolone with unusual substituents.

Authors:  Hikaru Abe; Manabu Kawada; Hiroyuki Inoue; Shun-ichi Ohba; Akio Nomoto; Takumi Watanabe; Masakatsu Shibasaki
Journal:  Org Lett       Date:  2013-04-17       Impact factor: 6.005

7.  Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions.

Authors:  Manabu Kawada; Hiroyuki Inoue; Ihomi Usami; Daishiro Ikeda
Journal:  Cancer Sci       Date:  2008-10-20       Impact factor: 6.716

8.  Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells.

Authors:  Manabu Kawada; Hiroyuki Inoue; Shun-Ichi Ohba; Tohru Masuda; Isao Momose; Daishiro Ikeda
Journal:  Int J Cancer       Date:  2010-02-15       Impact factor: 7.396

9.  Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2.

Authors:  Manabu Kawada; Hiroyuki Inoue; Shun-Ichi Ohba; Masaki Hatano; Masahide Amemiya; Chigusa Hayashi; Ihomi Usami; Hikaru Abe; Takumi Watanabe; Naoko Kinoshita; Masayuki Igarashi; Tohru Masuda; Daishiro Ikeda; Akio Nomoto
Journal:  J Antibiot (Tokyo)       Date:  2013-05-01       Impact factor: 2.649

10.  Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction.

Authors:  Manabu Kawada; Hiroyuki Inoue; Shun-ichi Ohba; Junjiro Yoshida; Tohru Masuda; Manabu Yamasaki; Ihomi Usami; Shuichi Sakamoto; Hikaru Abe; Takumi Watanabe; Takao Yamori; Masakatsu Shibasaki; Akio Nomoto
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

View more
  2 in total

Review 1.  Novel approaches for identification of anti-tumor drugs and new bioactive compounds.

Authors:  Manabu Kawada; Sonoko Atsumi; Shun-Ichi Wada; Shuichi Sakamoto
Journal:  J Antibiot (Tokyo)       Date:  2017-08-30       Impact factor: 2.649

2.  Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.

Authors:  Milcah C Scott; Hirotaka Tomiyasu; John R Garbe; Ingrid Cornax; Clarissa Amaya; M Gerard O'Sullivan; Subbaya Subramanian; Brad A Bryan; Jaime F Modiano
Journal:  Dis Model Mech       Date:  2016-11-03       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.